The Cigna Group CI
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 285.22B | 281.34B | 276.88B | 273.85B | 267.09B |
| Total Other Revenue | 1.10B | 1.05B | 1.01B | 1.05B | 984.00M |
| Total Revenue | 286.32B | 282.38B | 277.89B | 274.90B | 268.08B |
| Cost of Revenue | 260.30B | 256.58B | 252.47B | 249.34B | 242.47B |
| Gross Profit | 26.02B | 25.80B | 25.42B | 25.56B | 25.61B |
| SG&A Expenses | 12.36B | 12.11B | 12.09B | 13.56B | 14.03B |
| Depreciation & Amortization | 1.83B | 1.68B | 1.71B | 1.74B | 1.70B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 274.49B | 270.37B | 266.27B | 264.64B | 258.20B |
| Operating Income | 11.83B | 12.01B | 11.63B | 10.26B | 9.87B |
| Income Before Tax | 8.44B | 8.64B | 8.40B | 7.78B | 7.97B |
| Income Tax Expenses | 1.74B | 1.66B | 1.66B | 1.49B | 1.42B |
| Earnings from Continuing Operations | 6.71K | 6.98K | 6.74K | 6.29K | 6.55K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -718.00M | -567.00M | -452.00M | -331.00M | -403.00M |
| Net Income | 5.99B | 6.42B | 6.29B | 5.96B | 6.15B |
| EBIT | 11.83B | 12.01B | 11.63B | 10.26B | 9.87B |
| EBITDA | 14.72B | 14.74B | 14.38B | 13.03B | 12.57B |
| EPS Basic | 22.77 | 24.31 | 23.75 | 22.34 | 22.79 |
| Normalized Basic EPS | 22.03 | 22.94 | 22.45 | 19.51 | 18.12 |
| EPS Diluted | 22.67 | 24.18 | 23.60 | 22.19 | 22.66 |
| Normalized Diluted EPS | 21.92 | 22.83 | 22.31 | 19.38 | 18.02 |
| Average Basic Shares Outstanding | 1.05B | 1.06B | 1.06B | 1.07B | 1.08B |
| Average Diluted Shares Outstanding | 1.06B | 1.06B | 1.07B | 1.07B | 1.09B |
| Dividend Per Share | 6.19 | 6.14 | 6.09 | 6.04 | 5.93 |
| Payout Ratio | 27.25% | 25.31% | 25.70% | 27.04% | 26.01% |